Table 2.

Pretreatment quality of life and symptom burden by completion of first-line treatment in 137 newly referred patients with lung cancer, Herlev University Hospital, Denmark, 2016–17.

			Completed First-Line Treatment
	N	Total Mean (SD)	Yes Mean (SD)	No Mean (SD)	p-Value
Functioning scales (QLQ-C30)
Global QOL	135	62.1 (22.9)	68.2 (20.04)	55.2 (24.1)	<0.001 *
Physical function	137	77.3 (20.0)	83.6 (15.7)	69.9 (22.1)	<0.001 *
Role function	134	69.5 (27.99)	76.6 (25.7)	61.3 (27.4)	0.001 *
Emotional function	135	72.9 (22.4)	78.2 (19.1)	66.7 (24.5)	0.004 *
Cognitive function	135	87.7 (19.4)	90.9 (14.6)	83.6 (23.5)	0.035 *
Social function	134	86.9 (18.1)	92.0 (13.9)	80.9 (20.6)	<0.001 *
Symptom scales and single-items (QLQ-C30 and QLQ-LC13)
Fatigue	136	34.1 (23.6)	28.3 (20.3)	41.0 (25.4)	0.002 *
Nausea/vomiting	136	7.23 (15.8)	4.7 (13.7)	10.2 (17.7)	0.049 *
Pain	135	16.7 (21.8)	12.2 (16.6)	22.1 (25.9)	0.011 *
Dyspnea	134	36.3 (30.2)	30.6 (27.6)	43.2 (31.8)	0.016 *
Insomnia	136	28.2 (31.92)	23.9 (29.5)	33.3 (34.1)	0.085
Appetite loss	136	25.98 (31.9)	20.3 (29.6)	32.8 (33.3)	0.02 *
Constipation	134	7.5 (17.6)	6.3 (14.3)	8.9 (21.1)	0.42
Diarrhea	134	7.7 (17.3)	7.3 (16.9)	8.2 (17.9)	0.77
Financial difficulties	135	5.4 (16.9)	4.5 (14.9)	6.6 (19.1)	0.49
Dyspnea (lung cancer-specific)	137	27.4 (24.6)	22.8 (22.2)	32.7 (26.9)	0.02 *
Coughing	137	43.6 (29.9)	45.5 (29.5)	41.3 (30.4)	0.41
Hemoptysis	137	6.3 (16.4)	4.9 (14.3)	7.9 (18.7)	0.30
Sore mouth	137	3.6 (11.2)	3.6 (11.8)	3.7 (10.6)	0.96
Dysphagia	136	6.4 (16.5)	5.5 (17.6)	7.4 (15.2)	0.50
Peripheral neuropathy	136	5.6 (14.9)	4.95 (11.9)	5.5 (17.6)	0.58
Alopecia	134	4.2 (17.5)	4.1 (17.4)	4.4 (17.9)	0.90
Pain in chest	134	14.9 (22.2)	10.9 (19.3)	19.7 (24.6)	0.027 *
Pain in arm or shoulder	134	12.4 (22.6)	11.7 (22.4)	13.3 (23.1)	0.68
Pain in other parts	132	18.4 (27.7)	13.9 (24.1)	24.1 (31.1)	0.042 *

* Significant at the 5% level.